These agents, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess unique chemical structures leading to their varying pharmacological effects. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily recognized via its molecular formula – C14H15N6O4·H2SO4 – and characteristic spectral properties observed in techniques such as mass spectrometry and infrared assessment. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor blocker, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for complete identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate malignancy treatment, can be verified through its particular mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) spectroscopic data, ensuring its precise chemical characterization.
Directory: Abacavir Sulfate Sulfate (CAS 188062-50-2) & Related Materials
Explore a extensive listing detailing Abacavir Sulfate, identified by CAS number 188062-50-2, ADRAFINIL 63547-13-7 and a range of related substances. The offering includes various levels to satisfy precise research and manufacturing demands. Visitors will detailed data including analytical results and available containers options. Besides, examine our array of structurally akin substances that could be useful in a latest project. Our catalog is structured to facilitate efficient procurement of premium research ingredients.
Chemical Listing: Abarelix and Abirateron Acetate CAS Identifiers
For chemists and medicinal professionals needing precise pharmaceutical identification, accurate CAS codes are crucial. Specifically, abarelix, a gonadotropin-releasing-releasing hormone modulator used in managing prostate disease, is designated the Registry code 65572-21-8. Furthermore, abiraterone acetate, a significant treatment in advanced tumors, carries the Registry code 389292-17-3. Careful recording and confirmation of these CAS numbers are critical to guarantee accurate molecule recognition and related operations. Such numbers are publicly accessible through various research resources. Regularly refer authorized sources for the most data.
Pharmaceutical Ingredients: Abacavir Sodium , Abarelix, Abiraterone , Registry Identifiers
The recognition of critical pharmaceutical components often relies on precise chemical identifiers. Specifically, this article quickly examines three significant cases: Abacavir, a pyrimidine reverse enzyme inhibitor; Abarelix, a GnRH agonist; and Abiraterone, utilized in tumor management. These molecule is linked with a unique CAS number, supplying a consistent method for locating details and verifying accurate communication within the research industry. View the respective repositories for detailed records and related records.
CAS Registry Number Database: Information for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The vast Chemical Abstracts Service (CAS) registry is an essential resource for scientists and pharmaceutical professionals alike. This article briefly outlines records pertaining to three key therapeutic compounds: Abacavir Sulfate Salt, a medication used to treat HIV; Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist used in therapy; and Abiraterone Acetate Salt, a effective copyright biosynthesis inhibitor applied in the therapy of metastatic aggressive cancer. Finding the specific CAS code for each compound allows for certain identification and promotes correct scientific exploration. These unique identifiers are necessary for compound integrity and uniform reporting across the scientific community.
Utilizing API Chemical Data: Compound Recognition with Chemical Abstracts Service Numbers
Accurate product identification is critical in the material industry, and Application Programming Interface chemical data provides a consistent method. Specifically, CAS numbers act as individual labels for material compounds, permitting seamless association with collections and platforms. This approach furthermore bolsters records quality but also simplifies procedures related to research, acquisition, and legal submission. Furthermore, accessing this information via an Application Programming Interface supports automation and reduces the potential for human error.